Differential levels of Lhomocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.8, Iss.2, 2014-01, pp. : 566-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: A potential biomarker identified by proteomics

Oncology Reports, Vol. 27, Iss. 2, 2012-01 ,pp. : 318-324

Spandidos Publications

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T. Marth C. Kaern J. Nustad K. Kristensen G.B. Trope C.

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite

EpCAM-autoantibody levels in the course of disease of ovarian cancer patients

By Heubner Martin

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 626-630

Humana Press, Inc

Access to resources Recommend Favorite

Measurement of an apoptotic product in the sera of breast cancer patients

By Ueno T. Toi M. Biven K. Bando H. Ogawa T. Linder S.

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 769-774

Elsevier

Access to resources Recommend Favorite

Radioimmunoscintigraphy in Patients with Ovarian Cancer

By Kalofonos Haralabos P. Karamouzis Michalis V. Epenetos Agamemnon A.

Acta Oncologica, Vol. 40, Iss. 5, 2001-09 ,pp. : 549-557

Informa Healthcare

Access to resources Recommend Favorite